PortfoliosLab logoPortfoliosLab logo
NAGE vs. FFIV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NAGE vs. FFIV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Niagen Bioscience, Inc (NAGE) and F5 Networks, Inc. (FFIV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NAGE achieves a -46.86% return, which is significantly lower than FFIV's 52.60% return. Over the past 10 years, NAGE has underperformed FFIV with an annualized return of 1.58%, while FFIV has yielded a comparatively higher 13.13% annualized return.


NAGE

1D
-0.88%
1M
-7.65%
YTD
-46.86%
6M
-48.08%
1Y
-75.22%
3Y*
27.26%
5Y*
-18.04%
10Y*
1.58%

FFIV

1D
-0.44%
1M
-1.04%
YTD
52.60%
6M
49.55%
1Y
32.00%
3Y*
39.19%
5Y*
15.75%
10Y*
13.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NAGE vs. FFIV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NAGE
Niagen Bioscience, Inc
-46.86%19.89%270.98%-14.88%-55.08%-22.08%11.37%25.66%-41.67%77.64%
FFIV
F5 Networks, Inc.
52.60%1.51%40.50%24.72%-41.36%39.09%25.99%-13.81%23.48%-9.33%

Correlation

The correlation between NAGE and FFIV is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Jul 15, 2008

0.12

The correlation between NAGE and FFIV shifts across timeframes, from 0.12 (all time) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NAGE:

$285.83M

FFIV:

$22.32B

EPS

NAGE:

$0.22

FFIV:

$12.19

PE Ratio

NAGE:

15.50

FFIV:

31.95

PEG Ratio

NAGE:

0.13

FFIV:

1.40

PS Ratio

NAGE:

2.22

FFIV:

9.38

PB Ratio

NAGE:

3.47

FFIV:

6.12

Total Revenue (TTM)

NAGE:

$130.42M

FFIV:

$2.41B

Gross Profit (TTM)

NAGE:

$83.83M

FFIV:

$2.63B

EBITDA (TTM)

NAGE:

$13.37M

FFIV:

$889.95M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NAGE vs. FFIV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NAGE
NAGE Risk / Return Rank: 33
Overall Rank
NAGE Sharpe Ratio Rank: 11
Sharpe Ratio Rank
NAGE Sortino Ratio Rank: 00
Sortino Ratio Rank
NAGE Omega Ratio Rank: 11
Omega Ratio Rank
NAGE Calmar Ratio Rank: 22
Calmar Ratio Rank
NAGE Martin Ratio Rank: 1010
Martin Ratio Rank

FFIV
FFIV Risk / Return Rank: 6666
Overall Rank
FFIV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FFIV Sortino Ratio Rank: 6666
Sortino Ratio Rank
FFIV Omega Ratio Rank: 6666
Omega Ratio Rank
FFIV Calmar Ratio Rank: 6363
Calmar Ratio Rank
FFIV Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NAGE vs. FFIV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Niagen Bioscience, Inc (NAGE) and F5 Networks, Inc. (FFIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NAGEFFIVDifference
Sharpe ratioReturn per unit of total volatility

-2.46

Sortino ratioReturn per unit of downside risk

-4.39

Omega ratioGain probability vs. loss probability

0.65

1.19

-0.54

Calmar ratioReturn relative to maximum drawdown

-0.98

0.93

-1.91

Martin ratioReturn relative to average drawdown

-1.37

2.03

-3.40

NAGE vs. FFIV - Sharpe Ratio Comparison

The current NAGE Sharpe Ratio is -1.49, which is lower than the FFIV Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of NAGE and FFIV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NAGE vs. FFIV - Drawdown Comparison

The maximum NAGE drawdown since its inception was -97.00%, roughly equal to the maximum FFIV drawdown of -97.59%. Use the drawdown chart below to compare losses from any high point for NAGE and FFIV.


Loading charts...

Drawdown Indicators


NAGEFFIVDifference

Max Drawdown

Largest peak-to-trough decline

-97.00%

-97.59%

+0.59%

Max Drawdown (1Y)

Largest decline over 1 year

-76.61%

-34.73%

-41.88%

Max Drawdown (3Y)

Largest decline over 3 years

-76.61%

-34.73%

-41.88%

Max Drawdown (5Y)

Largest decline over 5 years

-88.57%

-47.42%

-41.15%

Max Drawdown (10Y)

Largest decline over 10 years

-93.65%

-54.59%

-39.06%

Current Drawdown

Current decline from peak

-81.96%

-4.79%

-77.17%

Average Drawdown

Average peak-to-trough decline

-75.72%

-40.13%

-35.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

55.03%

15.79%

+39.24%

Volatility

NAGE vs. FFIV - Volatility Comparison

Niagen Bioscience, Inc (NAGE) has a higher volatility of 12.88% compared to F5 Networks, Inc. (FFIV) at 8.01%. This indicates that NAGE's price experiences larger fluctuations and is considered to be riskier than FFIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NAGEFFIVDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.88%

8.01%

+4.87%

Volatility (6M)

Calculated over the trailing 6-month period

34.55%

24.66%

+9.89%

Volatility (1Y)

Calculated over the trailing 1-year period

50.52%

33.50%

+17.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.86%

29.99%

+46.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.72%

29.50%

+49.22%

Dividends

NAGE vs. FFIV - Dividend Comparison

Neither NAGE nor FFIV has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NAGE vs. FFIV - Financials Comparison

This section allows you to compare key financial metrics between Niagen Bioscience, Inc and F5 Networks, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
31.47M
0
(NAGE) Total Revenue
(FFIV) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NAGE and FFIV have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NAGE has higher volatility (12.88%) compared to FFIV (8.01%). In terms of maximum drawdown, NAGE dropped -97.00% vs FFIV's -97.59%.

FFIV currently has the higher Sharpe Ratio (0.96 vs -1.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NAGE and FFIV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer